«

»

China Drug Maker’s Shares Plunge On AstraZeneca Vaccine “Pause”

AstraZeneca has been considered to be a global leader in the race to develop a COVID-19 vaccine.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive